The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan

Cancer Research

Volumn 59, Issue 18, 1999, Pages 4715-4719

  Badcock, Graeme ^a   Pigott, Christine ^a   Goepel, John ^a   Andrews, Peter W ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; MONOCLONAL ANTIBODY; SIALIDASE; TRA 1 60 ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ANTIGENICITY; ARTICLE; CANCER CELL CULTURE; CHEMICAL LABELING; CONTROLLED STUDY; EMBRYONAL CARCINOMA; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; SEMINOMA; STRUCTURE ANALYSIS;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; ANTIGENS, SURFACE; BLOTTING, WESTERN; CARCINOMA, EMBRYONAL; GLYCOPEPTIDES; GLYCOPROTEINS; HUMANS; KERATAN SULFATE; N-ACETYLNEURAMINIC ACID; PROTEOCHONDROITIN SULFATES; PROTEOGLYCANS; SULFATES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033568542     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Damjanov, I. Pathogenesis of testicular germ cell tumours. Eur. Urol., 23: 2-7, 1993.
2. Dixon, F. J., and Moore, R. A. Atlas of Tumor Pathology: Tumors of the male sex organs (monograph). Washington, DC: Armed Forces Institute of Pathology, 1952.
3. Skakkebæk, E. E., Rajpert-de Meyts, E., Jørgensen, N., Carlsen, E., Petersen, P. M., Giwercman, A., Andersen, A-G., Jensen, T. K., Andersson, A-M., and Müller, J. Germ cell cancer and disorders of spermatogenesis: an environmental connection? Acta Pathol. Microbiol. Immunol. Scand., 106: 3-12, 1998.
4. Horwich, A. Testicular germ cell tumours: an introductory overview. In: A. Horwich (ed.), Testicular Cancer, pp. 1-17. London: Chapman and Hall, 1996.
5. Bosl, G. J., Geller, N. L., and Cirrincione, C. Serum tumor markers in patients with metastatic germ cell tumors of the testis. A 10 year experience. Am. J. Med., 75: 29-35, 1983.
6. Mason, M. D. Tumour markers. In: A. Horwich (ed.), Testicular Cancer, pp. 35-51. London: Chapman and Hall, 1996.
7. Andrews, P. W., Goodfellow, P. N., Shevinsky, L. H., Bronson, D., and Knowles, B. B. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture. Int. J. Cancer, 29: 523-531, 1982.
8. Andrews, P. W., Banting, G., Damjanov, I., Arnaud, D., and Avner, P. Three monoclonal antibodies defining distinct differentiation antigens associated with different high molecular weight polypeptides on the surface of human embryonal carcinoma cells. Hybridoma, 3: 347-361, 1984.
9. Kannagi, R., Cochran, N. A., Ishigami, F., Hakomori, S-i., Andrews, P. W., Knowles, B. B., and Solter, D. Stage-specific embryonic antigens SSEA-3 and -4 are epitopes of a unique globo-series ganglioside isolated from human teratocarcinoma cells. EMBO J., 2: 2355-2361, 1983.
10. Pera, M. F., Blasco-Lafita, M. J., Cooper, S., Mason, M. D., Mills, J., and Monaghan, P. Analysis of cell-differentiation lineage in human teratomas using new monoclonal antibodies to cytostructural antigens of embryonal carcinoma cells. Differentiation, 39: 139-149, 1988.
11. Rettig, W. J., Cordon-Cardo, C., Ng, J. S. C., Oettgen, H. F., Old, L. J, and Lloyd, K. O. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res., 45: 815-821, 1985.
12. Marrink, J., Andrews, P. W., Van Brummen, P. J., De Jong, H. J., Sleijfer, D. T., Schraffordt Koops, H., and Oosterhuis, J. W. TRA-1-60: a new serum marker in patients with germ-cell tumours. Int. J. Cancer, 49: 368-372, 1991.
13. Gels, M. E., Marrink, J., Visser, P., Sleijfer, D. T., Droste, J. H. J., Hoekstra, H. J, Andrews, P. W., and Koops, H. S. Importance of a new tumour marker TRA-1-60 in the follow-up of patients with clinical state I nonseminomatous testicular germ cell tumours. Ann. Surg. Oncol., 4: 321-327, 1997.
14. Andrews, P. W., Marrink, J., Hirka, G., Von Keitz, A., Sleijfer, D. T., and Gonczol, E. The surface antigen phenotype of human embryonal carcinoma cells: modulation upon differentiation. Rec. Res. Cancer Res., 123: 63-83, 1991.
15. Andrews, P. W., Casper, J., Damjanov, I., Duggan-Keene, M., Giwercman, A., Hata, J., Von Keitz, A., Looijenga, L. H. J., Millan, J. L., Oosterhuis, J. W., Pera, M. F., Sawada, M., Schmoll, H. J., Skakkebaek, N. E., and Van Putten, W. Comparative analysis of cell surface antigens expressed by cell lines derived from human germ cell tumours. Int. J. Cancer, 66: 896-816, 1996.
16. Cooper, S., Pera, M. F., Bennet, W., and Finch, J. T. A novel keratan sulphate proteoglycan from a human embryonal carcinoma cell line. Biochem. J., 286: 959-966, 1992.
17. Andrews, P. W., Damjanov, I,. Simon, D, Banting, G., Carlin, C., Dracopoli, N. C., and Fogh, J. Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: differentiation in vivo and in vitro. Lab. Invest., 50: 147-162, 1984.
18. Andrews, P. W. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev. Biol., 103: 285-293, 1984.
19. Bronson, D., Andrews, P. W., Solter, D., Cervenka, D., Lange, J., and Fraley, E. E. A cell line derived from a metastasis of a human testicular germ-cell tumor. Cancer Res., 40: 2500-2506, 1980.
20. Andrews, P. W., Bronson, D., Benham, F., Strickland, S., and Knowles, B. B. A. Comparative study of eight cell lines derived from human testicular teratocarcinoma. Int. J. Cancer, 26: 269-280, 1980.
21. Vogelzang, N. J., Bronson, D. L., Savino, D., Vessella, R. L., and Frayley, E. A. Human embryonal-yolk sac carcinoma model system in athymic mice. Cancer (Phila.), 55: 2584-2593, 1985.
22. Pattillo, R. A., and Gey, G. O. The establishment of a cell line of human hormone synthesizing trophoblastic cells in vitro. Cancer Res., 28: 1231-1236, 1968.
23. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumor Cells in Vitro, pp. 115-159. New York: Plenum Press, 1975.
24. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227: 680-685, 1970.
25. Cossu, G., Andrews, P. W., and Warren, L. Covalent binding of lactosaminoglycans and heparan sulphate to fibronectin synthesised by a human teratocarcinoma cell line. Biochem. Biophys. Res. Commun., 111: 952-957, 1983.
26. Rajpert-de Meyts, E., Jørgensen, N., Brøndum-Nielsen, K., Müller, J., and Skakkebaek, N. E. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. Acta Pathol. Microbiol. Immunol. Scand., 106: 198-206, 1998.
27. Stevens, L. C. The biology of teratomas. Adv. Morphol., 6: 1-31, 1967.
28. Andrews, P. W. Teratocarcinomas and human embryology: pluripotent human EC cell lines. Acta Pathol. Microbiol. Immunol. Scand., 106: 158-168, 1998.
29. Pierce, G. B. Teratocarcinoma. Introduction and perspectives. In: M. I. Sherman and D. Solter (eds.), Teratomas and Differentiation, pp. 3-12. New York: Academic Press, 1975.
30. Bernstine, E. G., Hooper, M. L., Grandchamp, S., and Ephrussi, B. Alkaline phosphatase activity in mouse teratoma. Proc. Natl. Acad. Sci. USA, 70: 3899-3902, 1973.
31. Chiquoine, A. D. The identification, origin and migration of primordial germ cells in the mouse embryo. Anat. Res. 118: 135-149, 1956.
32. Benham, F. J., Andrews, P. W., Bronson, D. L., Knowles, B. B., and Harris, H. Alkaline phosphatase isozymes as possible markers of differentiation in human teratocarcinoma cell lines. Dev. Biol., 88: 279-287, 1981.
33. Solter, D., and Knowles, B. B. Monoclonal antibody defining a stage specific mouse embryonic antigen SSEA-1. Proc. Natl. Acad. Sci. USA, 75: 5565-5569, 1978.
34. Brehm, A., Ovitt, C. E., and Schler, H. R. Oct 4: more than just a POUerful marker of the mammalian germ line. Acta Pathol. Microbiol. Immunol. Scand., 106: 114-126, 1998.
35. Thomson, J. A., Kalishman, J., Golos, T. G., Durning, M., Harris, C. P., Becker, R. A., and Hearn, J. P. Isolation of a primate embryonic stem cell line. Proc. Natl. Acad. Sci. USA, 92: 7844-7848, 1995.
36. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science (Washington DC), 282: 1145-1147, 1998.
37. Shamblott, M. J., Axelman, J., Wang, S., Bugg, E., Littlefield, J. W., Donovan, P. J., Blumenthal, P. D., Huggins, G. R., and Gearhart, J. D. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci., 95: 13726-13731, 1998.
38. Giwercman, A., Andrews, P. W., Jørgensen, N., Mller, J., Graem, N., and Skakkebaek, N. E. Immunohistochemical expression of embryonal marker TRA-1-60 in carcinoma in situ and germ cell tumors of the testis. Cancer (Phila.), 72: 1308-1314, 1993.
39. Fenderson, B. A., Radin, N., and Andrews, P. W. Differentiation antigens of human germ cell tumours: distribution of carbohydrate epitopes on glycolipids and glycoproteins analyzed using PDMP, an inhibitor of glycolipid synthesis. Eur. Urol., 23: 30-37, 1993.
40. Childs, R. A., Pennington, J., Uemura, K., Scudder, P., Goodfellow, P. N., Evans, M. J., and Feizi, T. High molecular weight glycoproteins are the major carriers of the carbohydrate differentiation antigens I, i, and SSEA-1 of mouse teratocarcinoma cells. Biochem J., 215: 491-503, 1983.
41. Muramatsu, H., Muramatsu, T., and Avner, P. Biochemical properties of the high-molecular-weight glycopeptides released from the cell surface of human teratocarcinoma cells. Cancer Res., 42: 1749-1752, 1982.
42. Mason, M. D., Pera, M. F., and Cooper, S. Possible presence of an embryonal carcinoma-associated proteoglycan in the serum of patients with testicular germ cell tumours. Eur. J. Cancer, 27: 300, 1991.